COVID-19 vaccines: modes of immune activation and future challenges

J. Teijaro, D. Farber

Nature reviews. Immunology, 2021

The new vaccines against SARS-CoV-2 are novel in terms of specificity, their wide dissemination across the global population and the inclusion of newly licensed mRNA platforms. We discuss here how the approved vaccines trigger innate immunity to promote durable immunological memory and consider the future implications of protecting populations with these vaccines.

Cited by 58 publications.

Field of study: Medicine

10.1038/s41577-021-00526-x